CoinsAQ
All news

CoinsAQ summary · neutral

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

What happened

ChatGPT maker OpenAI is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite of products.

Related asset context

Not financial advice. News and sentiment can be incomplete, delayed, or change quickly.